Variations in amount of TSST-1 produced by clinical methicillin resistant Staphylococcus aureus (MRSA) isolates and allelic variation in accessory gene regulator (agr) locus
Open Access
- 1 January 2009
- journal article
- research article
- Published by Springer Nature in BMC Microbiology
- Vol. 9 (1) , 52
Abstract
Staphylococcus aureus (S. aureus) is an important pathogen associated with both nosocomial and community-acquired infections and its pathogenicity is attributed to its potential to produce virulence factors. Since the amount of toxin produced is related to virulence, evaluating toxin production should be useful for controlling S. aureus infection. We previously found that some strains produce relatively large amounts of TSST-1; however, no reports have described the amount of TSST-1 produced by clinical isolates. Amounts of TSST-1 produced by clinical methicillin resistant S. aureus (MRSA) isolates were measured by Western blotting. We determined their accessory gene regulator (agr) class by PCR and investigated whether TSST-1 production correlates with variations in the class and structure of the agr. We found that 75% of surveyed MRSA isolates (n = 152) possessed the tst gene and that 96.7% belonged to agr class 2. The concentrations of TSST-1 secreted into culture supernatants by 34 strains measured by Western blotting differed 170-fold. Sequencing the entire agr locus (n = 9) revealed that some had allelic variations regardless of the amount of TSST-1 produced whereas sequencing the sar, sigma factor B and the tst promoter region revealed no significant changes. The amounts of TSST-1 produced by clinical MRSA isolates varied. The present results suggest that TSST-1 production is not directly associated with the agr structure, but is instead controlled by unknown transcriptional/translational regulatory systems, or synthesized by multiple regulatory mechanisms that are interlinked in a complex manner.Keywords
This publication has 19 references indexed in Scilit:
- Microbiological and Genotypic Analysis of Methicillin-Resistant Staphylococcus aureus BacteremiaAntimicrobial Agents and Chemotherapy, 2008
- Virulence regulation inStaphylococcus aureus: the need for in vivo analysis of virulence factor regulationFEMS Immunology & Medical Microbiology, 2004
- Changes in drug susceptibility and toxin genes in Staphylococcus aureus isolated from blood cultures at a university hospitalJournal of Infection and Chemotherapy, 2004
- Obvious Lack of Association Between Dynamics of Epidemic Methicillin-Resistant Staphylococcus aureus in Central Europe and agr Specificity GroupsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Prevalence of Genes Encoding Pyrogenic Toxin Superantigens and Exfoliative Toxins among Strains of Staphylococcus aureus Isolated from Blood and Nasal SpecimensJournal of Clinical Microbiology, 2003
- The effect of cell density and specific growth rate on accessory gene regulator and toxic shock syndrome toxin-1 gene expression inStaphylococcus aureusFEMS Microbiology Letters, 2003
- Analysis of the Genetic Variability of Genes Encoding the RNA III-Activating Components Agr and TRAP in a Population of Staphylococcus aureus Strains Isolated from Cows with MastitisJournal of Clinical Microbiology, 2002
- In Vitro Serial Passage of Staphylococcus aureus : Changes in Physiology, Virulence Factor Production, and agr Nucleotide SequenceJournal of Bacteriology, 2002
- Two‐Dimensional Analysis of Exoproteins of Methicillin‐Resistant Staphylococcus aureus (MRSA) for Possible Epidemiological ApplicationsMicrobiology and Immunology, 2002
- Evaluation of three rapid methods for detection of methicillin resistance in Staphylococcus aureus.2000